Discover 1,933 paid clinical trials in Denton, Texas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,933
FeaturedActive & Responsive
A Study Evaluating the Safety and Efficacy of Targeted Therapies in Subpopulations of Patients With Metastatic Colorectal Cancer (INTRINSIC)
A Study to Assess the Efficacy and Safety of Induction and Maintenance Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease
A Study Evaluating the Effectiveness and Safety of Risdiplam Administered in Pediatric Patients With Spinal Muscular Atrophy Who Experienced a Plateau or Decline in Function After Gene Therapy
for
Muscular Atrophy, Spinal
Location: Dallas TX, Little Rock AR, Aurora CO, Atlanta GA,
Sponsor: Hoffmann-La Roche
Sex: All
Age: 0 - 2
Code: NCT05861999
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Featured
A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
A Study to Assess Change in Disease Activity and Adverse Events (AEs) With Cariprazine in the Treatment of Depressive Episodes in Pediatric Participants Participants (10 to 17 Years of Age) With Bipolar I Disorder.
for
Depression, Bipolar I Disorder
Location: Coppell TX, Plano TX, Dallas TX, Mansfield TX,
Sponsor: AbbVie
Sex: All
Age: 10 - 17
Code: NCT04777357
Phase3, Recruiting
Featured
Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis
for
Crohn's Disease, Ulcerative Colitis
Location: Southlake TX, Dallas TX, Garland TX, Fort Worth TX,
Sponsor: AbbVie
Sex: All
Age: 18 - 70+
Code: NCT07697456
Phase2, Recruiting
Featured
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes
A Study to Assess the Efficacy and Safety of Induction Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease
for
Moderately to Severely Active Crohns Disease
Location: Fort Worth TX, Garland TX, Dallas TX, Tyler TX,
Sponsor: Hoffmann-La Roche
Sex: All
Age: 16 - 70+
Code: NCT06819891
Phase3, Recruiting
Featured
A Study to Assess the Adverse Events, Change in Disease Activity, and How Oral ABBV-711 Tablets Move Through the Body as a Monotherapy and in Combination With Intravenously Infused Budigalimab (ABBV-181), in Adults With Advanced Squamous Tumors
for
Advanced Squamous Tumors
Location: Irving TX, Chicago IL, Grand Rapids MI, Huntersville NC,
Sponsor: AbbVie
Sex: All
Age: 18+
Code: NCT07241039
Phase1, Recruiting
Featured
Study to Evaluate Adverse Events, Optimal Dose, and Change in Disease Activity, With Livmoniplimab in Combination With Budigalimab Plus Chemotherapy Versus IV Infused Pembrolizumab Plus Chemotherapy in Adult Participants With Untreated Metastatic Non-Squamous Non-Small Cell Lung Cancer (NSCLC)
for
Non-Small Cell Lung Cancer
Location: Plano TX, Houston TX, San Antonio TX, Westwood KS,
Sponsor: AbbVie
Sex: All
Age: 18+
Code: NCT06236438
Phase2, Phase3, Recruiting
Featured
A Study to Assess Adverse Events, Change in Disease Activity, and How Oral Emraclidine Moves Through the Body in Adult Participants With Schizophrenia
for
Schizophrenia
Location: Richardson TX, Austin TX, Little Rock AR,
Sponsor: AbbVie
Sex: All
Age: 18 - 65
Code: NCT07145918
Phase2, Recruiting
Featured
Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes
for
Obesity or Overweight, Type 2 Diabetes Mellitus
Location: Dallas TX, Norman OK, Oklahoma City OK, Tulsa OK,
Sponsor: Hoffmann-La Roche
Sex: All
Age: 18+
Code: NCT07351058
Phase3, Recruiting
Featured
Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities
for
Obesity, Overweight
Location: Dallas TX, Longview TX, Round Rock TX, Austin TX,
Sponsor: AbbVie
Sex: All
Age: 18 - 70+
Code: NCT07752979
Phase2, Recruiting
Featured
A Study to Evaluate the Efficacy, Safety, Pharmacodynamics (PD), and Pharmacokinetics (PK) of Selnoflast in Reducing Vascular Inflammation in Participants With Atherosclerosis at Risk for Major Adverse Cardiac Events
for
Atherosclerosis
Location: Dallas TX, Houston TX, San Antonio TX, St Louis MO,
Sponsor: Genentech, Inc.
Sex: All
Age: 18+
Code: NCT07448038
Phase2, Recruiting
Featured
A Study to Assess Adverse Events and Effectiveness of Gel Stent (XEN63) Implantation Using Ab Interno and Ab Externo Approaches in Adult Participants With Glaucoma
for
Primary Open Angle Glaucoma
Location: Dallas TX, Oklahoma City OK, Houston TX, New Orleans LA,
Sponsor: AbbVie
Sex: All
Age: 45+
Code: NCT06822738
Phase3, Recruiting
Featured
A Study to Assess Adverse Events and Change in Disease Activity Comparing Oral Upadacitinib to Subcutaneous Dupilumab in Children From 2 to Less Than 12 Years of Age With Moderate to Severe Atopic Dermatitis
for
Atopic Dermatitis
Location: Arlington TX, Mansfield TX, San Antonio TX,